• 한국산학기술학회논문지
• /
• 제11권7호
• /
• pp.2436-2443
• /
• 2010

본 연구는 현 우리나라에서 가족관광시 발생되는 갈등유발요인을 규명함으로써, 가족간의 갈등유발요인의 예측은 물론 이를 통해 변화된 가족관광시 상이한 갈등유발요인확인은 관광행동을 연구하는 기초자료를 제공하고자 하였다. 이에 본 연구를 통하여 첫째, 관광학 측면 즉, 관광객행동론 이해측면에서 가족관광시 가족생애주기별 의사결정자와 각 구성원들간 상이한 갈등유발요인을 규명하였다. 이를 통하여 첫째, 가족관광의사결정시 각 이해관계자들 간의 의사소통이 원활해 질 것으로 기대할 수 있다. 둘째, 각 이해관계자들의 의견수렴으로 상호간의 신뢰를 얻을 수 있을 것으로 기대 할 수 있다. 셋째, 가족간의 갈등유발요인의 예측으로 가족간의 의사결정시 시행착오를 예방할 수 있을 것으로 기대할 수 있을 것으로 사료된다.

• Journal of Hospice and Palliative Care
• /
• 제25권1호
• /
• pp.1-11
• /
• 2022

The Act on Decisions on Life-Sustaining Treatment has been in effect since 2018 for end-of-life patients. However, only 20~25% of deaths of terminally ill patients comply with the law, while the remaining 75~80% do not. There is significant confusion in how the law distinguishes between those in the terminal stage and those in the dying process. These 2 stages can be hard to distinguish, and they should be understood as a single unified "terminal stage." The number of medical institutions eligible for life-sustaining treatment decisions should be legally expanded to properly reflect patients' wishes. To prevent unnecessary suffering resulting from futile life-sustaining treatment, life-sustaining treatment decisions for terminal patients without the needed familial relationships should be permitted and made by hospital ethics committees. Adult patients should be permitted to assign a legal representative appointed in advance to represent them. Medical records can be substituted for a patient's judgment letter (No. 9) and an implementation letter (No. 13) for the decision to suspend life-sustaining treatment. Forms 1, 10, 11, and 12 should be combined into a single form. The purpose of the Life-sustaining Medical Decisions Act is to respect patients' right to self-determination and protect their best interests. Issues related to the act that have emerged in the 3 years since its implementation must be analyzed, and a plan should be devised to improve upon its shortcomings.

• 한국발생생물학회지:발생과생식
• /
• 제14권2호
• /
• pp.143-154
• /
• 2010

이 글은 연명치료의 중단에 관해 서로 상반된 결론을 내렸던 보라매병원 판결(대법원 2002도995)과 신촌세브란스병원 판결(대법원 2009다17471)이 전통적으로 의료사회를 지배했던 의사후견주의 혹은 가족주의적 후견주의의 이념을 어떠한 방식으로 수용하거나 변형 또는 거부하고 있는지를 분석한다. 보라매병원 사건에서 법원이 '의사'의 자연법적 의무를 강조한 것은 의사가 자연법 발견의 능력이 있음을 전제하는 전통적인 의사후견주의적 인식에서 출발한 것이긴 하다. 하지만 법원은 종국적으로는 자연법 발견의 최종적 주체를 '법원'으로 상정함으로써 스스로를 환자에 대한 독자적 후견인으로 규정한 셈이 되었다. 뿐만 아니라 법원은 환자 가족의 결정 역시 법원의 자연법적 결정 뒤로 물러나게 함으로써 가족주의적 후견주의로부터 탈피했지만, 법원의 우월성을 드러낼 뿐 가족의 결정이 가질 수 있는 의미를 충분히 존중하지는 못했다. 신촌세브란스병원 사건에서는 이와는 달리 환자의 자기결정권이 갖는 의미가 무엇인지를 좀더 명확히 언급한다. 뿐만 아니라 자기결정권의 행사범위는 '내용적'으로, 그리고 '시간적'으로도 확대된다. 하지만 이 판결 역시 진정한 의미에서의 의료적 자율성에 대한 인식을 충분히 보여주진 못했다. 법원은 의사나 병원윤리위원회의 결정의 중요성을 인식하면서도 행위에 대한 실체적인 판단의 권한을 여전히 유지하고 있는 듯하며, 환자가족의 결정을 중시하긴 하지만 여전히 정황에 대한 (법원의) '객관적' 판단을 강조함으로써 결정주체로서의 권위를 포기하지 않는다.

• Clinical and Experimental Pediatrics
• /
• 제60권8호
• /
• pp.254-260
• /
• 2017

Purpose: Seasonal influenza can be prevented by vaccination. Disease prevention in children aged <60 months is of particular importance because of the associated familial and societal burden. Considering that caretakers make the decision to vaccinate their children, the identification of drivers and barriers to vaccination is essential to increase influenza vaccination coverage. Methods: A total of 639 parents participated in the pre- and posteducational survey and 450 parents participated in the study via telephone interviews. The participating parents were asked to rank their agreement with each statement of the survey questionnaire on a scale from 1 (strongly disagree) to 5 (strongly agree), and the scores between pre- and postintervention were compared. Results: Before the educational intervention, 105 out of 639 participants reported not to agree to vaccinate their children against influenza. After the intervention, 46 out of the 105 parents changed their opinions about childhood vaccination. The physicians' recommendation received the highest agreement score and was the most important driver to vaccination, whereas the cost of vaccination was the strongest factor for not vaccinating children. In general, the participants significantly changed the agreement scores between pre- and postintervention. However, the unfavorable opinions about vaccination and the convenience of receiving the influenza vaccine did not change significantly. Conclusion: The results of this study indicate that a specific educational intervention involving caregivers is very effective in increasing the influenza vaccination coverage of children aged less than 60 months.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권7호
• /
• pp.4339-4345
• /
• 2013

Background: The purpose of this study was to evaluate the prevalence of BRCA1 (MIM: 113705) founder mutations in familial breast cancer (BC) patients with high risks in Iran. BRCA1 is among the cancer susceptibility genes best known for high penetrance mutations. BRCA1 genotyping is now used to determine patient counseling, management decisions, and prognosis of this syndrome. Materials and Method: Thirty nine patients with clinical BC and 29 high risk healthy women, related to the patients, participated in the study. DNA from blood samples was extracted and analyzed by PCR and SSCP methods in order to find 185delAG and 5382insC founder mutations. In addition, a 251bp fragment of BRCA1's exon 11 was amplified and analyzed for determination of new mutations. Results: The data indicated the presence of 185delAG and 5382insC founder mutations in both groups studied. Two out of 39 BC patients (5.1%) and one out of 29 relatives (3.4%) were suspected to be carriers of 185delAG mutations. However, we found only one patient (2.6%) to be a carrier of a 5382insC mutation. Also, 2 women (5.1%) of the patient group and 3 n (10.3%) of relatives group were identified as carriers of unclarified mutations in the 251bp fragment of the BRCA1 gene. The carriers of BRCA1 founder mutations have a high lifetime risk of breast cancer. Conclusions: Therefore, these data are useful in counseling of individuals with a significant family history of breast cancer.

• Journal of Genetic Medicine
• /
• 제4권1호
• /
• pp.1-5
• /
• 2007

Unprecedented amount of genetic information being generated from the result of Human Genome Project (HGP) and advances in genetic research is already forcing changes in the paradigm of health and disease. The ultimate goal of genetic medicine is to use genetic information and technology to develop new ways of treatment or even prevention of the disease on an individual level for 'personalized medicine'. Genetics is play ing an increasingly important role in the diagnosis, monitoring and management of common multifactorial diseases in addition to rare single-gene disorders. While wide range of genetic testing have provided benefits to patients and family, uncertainties surrounding test interpretation, the current lack of available medical options for the diseases, and risks for discrimination and social stigmatization may remain to be resolved. However an increasing number of genetic tests are becoming commercially available, including direct to consumer genetic testing, yet public is often unaw are of their clinical and social implications. The personal nature of information generated by a genetic test, its power to affect major life decisions and family members, and its potential misuse raise important ethical considerations. Therefore appropriate genetic counseling is needed for patient to be informed with the benefits, limitations and risks of genetic tests, prior to informed consent for the tests. Physician also should be familiar with the legal and ethical issues involved in genetic testing to tell patients how w ell a particular genetic risk factor relates with likelihood of disease, and be able to provide appropriate genetic counseling. Genetic counseling become a mandatory requirement as global standard for many genetic testing such as prenatal diagnosis, presymtomatic DNA diagnostic tests and cancer susceptibility gene test for familial cancer syndrome. In oder to meet the challenge of genetic medicine of 21 century in korean health care system, professional education program and certification board for medical genetics specialist including non-MD genetic counselors should be addressed by medical society and regulatory policy of national health insurance reimbursement for genetic counseling to be in place to promote the implementation of clinical genetic service including genetic counseling for proper genetic testing.